Most Read Articles
22 May 2017
Chronic obstructive pulmonary disease (COPD) is currently the 10th commonest cause of death in Singapore, with a disease burden of 5.9 percent according to a 2015 population-based survey (EPIC-Asia survey) in Singapore. Pearl Toh spoke with Dr Augustine Tee, chief and senior consultant of the Department of Respiratory and Critical Care Medicine at Changi General Hospital (CGH) in Singapore, on how COPD is often underdetected in the primary care population as symptoms are not specific and diagnosis requires a combination of clinical risk factors, symptoms and spirometry testing.
15 Aug 2017
New drug applications approved by US FDA as of 1 - 15 August 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
04 Aug 2017
Chronic obstructive pulmonary disease (COPD) is the fourth cause of global mortality, with experts predicting a potential future rise in the prevalence rates of COPD. 
11 May 2016

In conjunction with World Asthma Day which falls on 3rd May 2016, MIMS Doctor speaks to a renowned respiratory medicine specialist, Dato' Dr. Hj Abdul Razak Abdul Muttalif, regarding the chronic airway disease.

Physical activity, cardiorespiratory fitness reduce anxiety, panic, depressive symptoms

27 Sep 2017
Sweating it out once a week can still keep you as fit as another who works out daily, say researchers

Physical activity and cardiorespiratory fitness seem to reduce the odds of generalized anxiety, panic and depressive symptoms, a recent cross-sectional study has shown. In contrast, muscle strengthening activities exert no effects on these symptoms.

Males in the top tertile of moderate-to-vigorous physical activity (MVPA) had significantly lower chances of having generalized anxiety, panic and depressive symptoms, determined either through the Composite International Diagnostic Interview (CIDI) or through self-assessments (adjusted odds ratio [OR], 0.68; 95 percent CI, 0.48 to 0.96; p=0.02), than those in the bottom tier.

Females in the top MVPA tertile also had lower chances of manifesting the said symptoms than those in the bottom tertile (adjusted OR, 0.54; 0.29 to 1.02; p=0.05).

Compared with participants who had low fitness, those with high cardiorespiratory fitness had significantly lower odds of self-reported or CIDI-determined symptoms of general anxiety, panic and depression (adjusted OR, 0.60; 0.39 to 0.92; p=0.02) after adjusting or age, sex, ethnicity and other potential confounders.

In contrast, meeting the muscle strengthening guideline showed no significant associations with generalized anxiety, panic and depressive symptoms even after adjusting for potential confounders such as aerobic physical activities.

Taking all three variables into consideration, a dose-dependent association between the composite variable and CIDI-determined generalized anxiety, panic and depressive symptoms was observed.

Specifically, individuals who met the guidelines of one (OR, 0.61; 0.29 to 1.31; p=0.20), two (OR, 0.46; 0.19 to 1.11; p=0.08) or three (OR, 0.29; 0.10 to 0.77; p=0.01) of the above parameters had lower odds of manifesting the symptoms compared with those who fulfilled none of the guideline values.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
22 May 2017
Chronic obstructive pulmonary disease (COPD) is currently the 10th commonest cause of death in Singapore, with a disease burden of 5.9 percent according to a 2015 population-based survey (EPIC-Asia survey) in Singapore. Pearl Toh spoke with Dr Augustine Tee, chief and senior consultant of the Department of Respiratory and Critical Care Medicine at Changi General Hospital (CGH) in Singapore, on how COPD is often underdetected in the primary care population as symptoms are not specific and diagnosis requires a combination of clinical risk factors, symptoms and spirometry testing.
15 Aug 2017
New drug applications approved by US FDA as of 1 - 15 August 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
04 Aug 2017
Chronic obstructive pulmonary disease (COPD) is the fourth cause of global mortality, with experts predicting a potential future rise in the prevalence rates of COPD. 
11 May 2016

In conjunction with World Asthma Day which falls on 3rd May 2016, MIMS Doctor speaks to a renowned respiratory medicine specialist, Dato' Dr. Hj Abdul Razak Abdul Muttalif, regarding the chronic airway disease.